The 2024 ELN risk stratification was developed with evidence from an exploratory analysis of pooled data from the phase 3 VIALE-A trial and a phase 1 b study of azacitidine plus venetoclax.

You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Tests do not consistently influence risk classification or treatment decisions; authors call for well-designed trials on role of GC tests in newly diagnosed PCa. (HealthDay News) — For patients ...

Pull requests help you collaborate on code with other people. As pull requests are created, they’ll appear here in a searchable and filterable list. To get started, you should create a pull request.

Abstract: Leukemia, a prevalent childhood cancer affecting the blood and bone marrow, necessitates a proactive approach to risk mitigation through lifestyle adaptations ... which was utilized for ...

Delve into the implications of South Africa's FATF grey listing and the inconsistencies in global terrorism financing laws.

Explore how pro-crypto policies are evolving, why banks are playing catch-up, and key strategies to get ahead in the digital ...

On January 9, 2025, the OECD published a new Policy Paper on the Tokenisation of Assets in Financial Markets, highlighting ...

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with localized prostate cancer (PCa), there is a need for ...

A stock image of a chopped cucumber on a board. A Class I risk classification has been awarded by the FDA. A stock image of a chopped cucumber on a board. A Class I risk classification has been ...